Browse > Article

Type 2 GM1 Gangliosidosis Presented with Developmental Regression: A Case Report  

Ko, Jung Min (Department of Pediatrics, Seoul National University College of Medicine)
Cho, Tae Joon (Department of Orthopedic Surgery, Seoul National University College of Medicine)
Chae, Jong-Hee (Department of Pediatrics, Seoul National University College of Medicine)
Publication Information
Journal of The Korean Society of Inherited Metabolic disease / v.14, no.2, 2014 , pp. 182-185 More about this Journal
Abstract
GM1 gangliosidosis is a rare autosomal recessively inherited metabolic disease due to deficiency of ${\beta}$-galactosidase caused by mutations in the GLB1 gene. There have been three clinical subgroups in GM1 gangliosidosis, however it is difficult to differentiate because there is considerable overlap between classical phenotypes and clinical and imaging findings among the subgroups. Here, we report a Korean girl with type 2 GM1 gangliosidosis, who showed dysostosis multiplex and progressive neurological deterioration. Developmental regression was first noted at the age of 9 months, and she was diagnosed as GM1 gangliosidosis by ${\beta}$-galactosidase enzyme analysis and GLB1 mutation analysis at the age of 16 months.
Keywords
GM1 gangliosidosis; GLB1; Lysosomal storage disease; Dysostosis multiplex;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hofer D, Paul K, Fantur K, Beck M, Burger F, Caillaud C, et al. GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase. Hum Mutat 2009;30:1214-21.   DOI   ScienceOn
2 Hofer D, Paul K, Fantur K, Beck M, Roubergue A, Vellodi A, et al. Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations. Clin Genet 2010;78:236-46.   DOI   ScienceOn
3 Suzuki Y, Sakuraba H, Oshima A, Yoshida K, Shimmoto M, Takano T, et al. Clinical and molecular heterogeneity in hereditary beta-galactosidase deficiency. Dev Neurosci. 1991;13:299-303.   DOI
4 Shield JP, Stone J, Steward CG. Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis. J Inherit Metab Dis 2005;28:797-8.   DOI
5 Okada S, O'Brien JS. Generalized gangliosidosis: beta-galactosidase deficiency. Science 1968;160:1002-4.   DOI   ScienceOn
6 Suzuki Y, Nanba E, Matsuda J, Higaki K, Oshima A. $\beta$-galactosidase deficiency ($\beta$-Galactosidosis): GM1 gangliosidosis and Morquio B disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID), McGraw-Hill, New York, 2014.
7 Suzuki Y, Nanba E. $\beta$-Galactosidase deficiency ($\beta$-galactosidosis) GM1-gangliosidosis and Morquio B disease, The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, New York, 2001.
8 Yoshida K, Oshima A, Shimmoto M, Fukuhara Y, Sakuraba H, Yanagisawa N, et al. Human betagalactosidase gene mutations in G(M1)-gangliosidosis: a common mutation among Japanese adult/chronic cases. Am J Hum Genet 1991;49:435-42.
9 Nishimoto J, Nanba E, Inui K, Okada S, Suzuki K. GM1-gangliosidosis (genetic beta-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients. Am J Hum Genet 1991;49:566-74.
10 Sinigerska I, Chandler D, Vaghjiani V, Hassanova I, Gooding R, Morrone A, et al. Founder mutation causing infantile GM1-gangliosidosis in the Gypsy population, Mol Genet Metab 2006;88:93-5.   DOI   ScienceOn
11 Celtikci B, Aydin HI, Sivri S, Sonmez M, Topcu M, Ozkara HA. Four novel mutations in the $\beta$-galactosidase gene identified in infantile type of GM1 gangliosidosis. Clin Biochem 2012;45:571-4.   DOI   ScienceOn
12 Brunetti-Pierri N, Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab 2008;94:391-6.   DOI   ScienceOn